Disc Medicine, Inc. (IRON)

Health Care ยท Pharmaceutical Preparations

Disc Medicine, Inc. (IRON) is listed on Nasdaq, where its shares have traded since February 8, 2021. SentiSense covers Disc Medicine, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. John Quisel is its chief executive officer. The company reports 173 employees, and its corporate website is www.discmedicine.com.

About Disc Medicine, Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 211 institutions reported holding IRON, with 42.8 million shares worth $3.1 billion in aggregate. The largest reported holders were FMR, BlackRock and RA Capital Management. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.

More on IRON

  • IRON sentiment: whether news and social coverage of Disc Medicine, Inc. leans bullish or bearish, and the stories driving it.
  • IRON ownership: all 211 reporting institutions, plus insider and congressional trades.
  • IRON financials: revenue, net income, operating margin and free cash flow by quarter and year.

SentiSense also tracks daily options readings for Disc Medicine, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.

Frequently asked questions

What does Disc Medicine, Inc. do?

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases.

What sector is IRON in?

SentiSense classifies Disc Medicine, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.

Where does IRON stock trade?

Disc Medicine, Inc. (IRON) is listed on Nasdaq, where its shares have traded since February 8, 2021.

Who is the CEO of Disc Medicine, Inc.?

John Quisel is the chief executive officer of Disc Medicine, Inc..